Clinical trial
Secondary Prophylaxis After Variceal Bleeding in Non-Responders
NCT00450164 · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Other · Completed
Key facts
| NCT number | NCT00450164 |
|---|---|
| Title | Secondary Prophylaxis After Variceal Bleeding in Non-Responders |
| Official title | Secondary Prophylaxis After Variceal Bleeding: Combined Treatment With Endoscopic Ligation and Nadolol Against Nadolol Associated With Mononitrate of Isosorbide or Prazosin According to Hemodynamic Response. |
| Acronym | KT-2000 |
| Lead sponsor | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastrointestinal Hemorrhage, Portal Hypertension, Cirrhosis |
| Intervention type | Drug, Procedure |
| Interventions | esofagic varices ligation, Nadolol, Isosorbide mononitrate, Prazosin |
| Enrollment | 50 |
| Start date | Nov 1, 2000 |
| Completion | Jun 1, 2004 |
| First posted | Mar 21, 2007 |
| Last update posted | Mar 21, 2007 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: